
Using Annual Product Review (APR/PQR) to Detect Process Drift
Use APR/PQR data to identify emerging changes in process and product performance, connect quality trends, and assess when findings call for investigation, CAPA, revalidation, or changes to existing controls.
Session overview
This webinar presents a practical approach to reviewing APR/PQR data, recognizing emerging changes in process and product performance, and determining when the evidence warrants investigation, CAPA, revalidation, or changes to existing controls.
An APR/PQR brings together records that are often assessed separately during the year, including process and release results, deviations, OOS investigations, stability data, complaints, recalls, changes, validation status, and corrective actions. Reviewing these records together helps establish whether a process remains consistent or whether patterns suggest a meaningful change in performance.
An individual result may meet acceptance criteria while the longer-term trend still requires attention. This session explores how APR/PQR reviews can reveal adverse or emerging signals across batches and reporting periods, how to assess those signals against the validated state, and when findings support investigation, CAPA, revalidation, specification or control changes, or other product and process improvements.
Connect annual review data with quality decisions
Recognize Patterns Beyond Individual Batch Reviews
Changes in process performance may become apparent only when results are reviewed across multiple batches and reporting periods. An effective APR/PQR connects process data, quality results, stability findings, deviations, complaints, changes, and previous reviews to help identify and address adverse trends before they are treated as unrelated events.
Turn Review Findings Into Quality Decisions
The session begins with APR/PQR regulatory expectations and the records to include, then examines how to evaluate trends across process and quality data. It moves on to interpreting significant findings and deciding when investigation, CAPA, revalidation, specification or control changes, or further process improvement may be appropriate.
What the session covers
- FDA, EU GMP, and ICH expectations for effective APR/PQR reviews
- Trending critical in-process controls, release results, and other process performance data
- Reviewing stability data, OOS investigations, deviations, complaints, recalls, and changes for emerging signals
- Recognizing adverse trends and signs of process drift
- Assessing when APR/PQR findings warrant investigation, CAPA, revalidation, or changes to controls
- Documenting conclusions, follow-up actions, and continued assessment of the validated state
Designed for your role
Meet the faculty

Danielle DeLucy, MS, owns ASA Training and Consulting, LLC, which supports pharmaceutical and biologics companies with quality systems and regulatory compliance. Her industry experience spans Quality Control, Quality Assurance, product quality, and manufacturing oversight. She has supported regulatory inspections and inspection preparation, and helps organizations address quality-system remediation, warning letter and consent decree responses, CAPA, validation, and other GMP compliance activities.